Vallerie McLaughlin, MD
Vallerie V. McLaughlin, MD, is the Kim A. Eagle, MD, Endowed Professor of Cardiovascular Medicine, Interim Chief Clinical Officer for Ambulatory Care Cardiovascular Services, and Director of the Pulmonary Hypertension (PH) Program at the University of Michigan, Ann Arbor, MI. She is a Fellow of the American College of Cardiology and the American Heart Association. She has served as Chair of the American Heart Association “Women in Cardiology” Committee, Chair of the American College of Cardiology/American Heart Association Clinical Expert Consensus Document on PH, member of the American College of Cardiology Scientific Sessions Program Committee, and member of the Scientific Committee for the World Symposium on Pulmonary Hypertension 2008, 2013, and 2018. Professor McLaughlin is a past Chair of the Scientific Leadership Council of the Pulmonary Hypertension Association, past Editor-in-Chief of Advances in Pulmonary Hypertension and past Chair of the Pulmonary Hypertension Association Board of Trustees. She was inaugurated as a charter member into the Clinical Excellence Society at the University of Michigan and is a founding member of the World Symposia on Pulmonary Hypertension Association. Her research interests focus on PH.
Financial relationships
-
Attribution:SelfType of financial relationship:Consulting FeeIneligible company:Aerovate, Apollo, CVS/Caremark, L.L.C., Corvista, Gossamer Bio, Janssen, Keros, Liquidia, Merck, Morphic, Regeneron, Respira, Roivant, United TherapeuticsDate added:01/06/2025Date updated:01/06/2025
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:PI-Aerovate, Enzyvant/Altavant, Gossamer-Bio, Keros, Sonovie, Sub-I Janssen, Merck/AceleronDate added:01/06/2025Date updated:01/06/2025